<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01622803</url>
  </required_header>
  <id_info>
    <org_study_id>KH0LEE</org_study_id>
    <nct_id>NCT01622803</nct_id>
  </id_info>
  <brief_title>Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction</brief_title>
  <official_title>Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Internal biliary drainage using stent is used for malignant hilar obstruction such as
      cholangiocarcinoma, hepatocellular carcinoma and other malignancy including metastasis.

      Bilateral drainage is more physiologic and have more long patency than unilateral drainage.

      There are two methods of bilateral drainage: Y-stent and side by side.

      However there are no clinical data about comparing the effectiveness of these two methods.

      Therefore the investigators want to compare the clinical outcomes of two methods:

      Y-stent and side by side.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Patients enrollment problem
  </why_stopped>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time taken to insert bilateral stent</measure>
    <time_frame>After the ERCP procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Bile Duct Neoplasm</condition>
  <condition>Obstructive Jaundice</condition>
  <arm_group>
    <arm_group_label>parallel stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>parallel stent insertion group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Y-stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Y-stent insertion group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>parallel stent</intervention_name>
    <description>bilateral parallel stent insertion (right and left side)</description>
    <arm_group_label>parallel stent</arm_group_label>
    <other_name>bilateral pig tail plastic stent</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Y-stent (BONASTENT M-Hilar)</intervention_name>
    <description>Bilateral Y-stent insertion (stent in stent type)</description>
    <arm_group_label>Y-stent</arm_group_label>
    <other_name>BONASTENT M-Hilar, Standard Sci Tech Inc, Seoul, South Korea</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age â‰¥ 18 years

          -  patient who have obstructive jaundice (bilirubin &gt; 2.0mg/dl) due to hilar malignancy

        Exclusion Criteria:

          -  patients with endoscopic retrograde cholangiogram is not possible

          -  bleeding tendency (PT INR &gt; 1.5, platelet &lt; 50,000)

          -  poor general condition (ECOG 3-4) or cardiopulmonary deterioration

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kwang hyuck Lee, MD, phD</last_name>
    <role>Study Director</role>
    <affiliation>Division of Gastroenterology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2012</study_first_submitted>
  <study_first_submitted_qc>June 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2012</study_first_posted>
  <last_update_submitted>April 24, 2016</last_update_submitted>
  <last_update_submitted_qc>April 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Kwang Hyuck Lee</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
    <mesh_term>Bile Duct Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

